US 11859000
Anti-CCR8 antibodies and uses thereof
granted A61KA61K39/39541A61K47/6849
Quick answer
US patent 11859000 (Anti-CCR8 antibodies and uses thereof) held by VACCINEX, INC. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/39541, A61K47/6849, A61P, A61P35/00